Evaluating drug-free remission with abatacept in early rheumatoid arthritis: Results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period Academic Article uri icon

Overview

MeSH Major

  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Immunoconjugates
  • Methotrexate

abstract

  • NCT01142726.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4283672

Digital Object Identifier (DOI)

  • 10.1136/annrheumdis-2014-206106

PubMed ID

  • 25367713

Additional Document Info

start page

  • 19

end page

  • 26

volume

  • 74

number

  • 1